Clearside Cash Flow To Debt Ratio from 2010 to 2024

CLSD Stock  USD 1.29  0.11  7.86%   
Clearside Biomedical's Cash Flow To Debt Ratio is increasing over the years with slightly volatile fluctuation. Cash Flow To Debt Ratio is expected to dwindle to -0.45. During the period from 2010 to 2024 Clearside Biomedical Cash Flow To Debt Ratio annual values regression line had coefficient of variation of (95.13) and r-squared of  0.44. View All Fundamentals
 
Cash Flow To Debt Ratio  
First Reported
2010-12-31
Previous Quarter
(0.43)
Current Value
(0.45)
Quarterly Volatility
10.1136578
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Clearside Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearside Biomedical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 63.6 K, Interest Expense of 9.8 M or Other Operating Expenses of 35.5 M, as well as many indicators such as Price To Sales Ratio of 8.35, Dividend Yield of 0.0 or Days Sales Outstanding of 8.24. Clearside financial statements analysis is a perfect complement when working with Clearside Biomedical Valuation or Volatility modules.
  
Check out the analysis of Clearside Biomedical Correlation against competitors.
For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.

Latest Clearside Biomedical's Cash Flow To Debt Ratio Growth Pattern

Below is the plot of the Cash Flow To Debt Ratio of Clearside Biomedical over the last few years. It is Clearside Biomedical's Cash Flow To Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clearside Biomedical's overall financial position and show how it may be relating to other accounts over time.
Cash Flow To Debt Ratio10 Years Trend
Slightly volatile
   Cash Flow To Debt Ratio   
       Timeline  

Clearside Cash Flow To Debt Ratio Regression Statistics

Arithmetic Mean(10.63)
Coefficient Of Variation(95.13)
Mean Deviation8.64
Median(6.63)
Standard Deviation10.11
Sample Variance102.29
Range25.0905
R-Value0.66
Mean Square Error62.23
R-Squared0.44
Significance0.01
Slope1.49
Total Sum of Squares1,432

Clearside Cash Flow To Debt Ratio History

2024 -0.45
2023 -0.43
2022 -10.4
2021 -15.9
2020 -6.63
2019 -4.22
2018 -7.94

About Clearside Biomedical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Clearside Biomedical income statement, its balance sheet, and the statement of cash flows. Clearside Biomedical investors use historical funamental indicators, such as Clearside Biomedical's Cash Flow To Debt Ratio, to determine how well the company is positioned to perform in the future. Although Clearside Biomedical investors may use each financial statement separately, they are all related. The changes in Clearside Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Clearside Biomedical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Clearside Biomedical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Clearside Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Flow To Debt Ratio(0.43)(0.45)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Clearside Stock

When determining whether Clearside Biomedical is a strong investment it is important to analyze Clearside Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearside Biomedical's future performance. For an informed investment choice regarding Clearside Stock, refer to the following important reports:
Check out the analysis of Clearside Biomedical Correlation against competitors.
For information on how to trade Clearside Stock refer to our How to Trade Clearside Stock guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearside Biomedical. If investors know Clearside will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearside Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.55)
Revenue Per Share
0.132
Quarterly Revenue Growth
56.5
Return On Assets
(0.38)
Return On Equity
(13.10)
The market value of Clearside Biomedical is measured differently than its book value, which is the value of Clearside that is recorded on the company's balance sheet. Investors also form their own opinion of Clearside Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Clearside Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearside Biomedical's market value can be influenced by many factors that don't directly affect Clearside Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearside Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearside Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearside Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.